| Financial Year |
March 31 2023 |
| Monetary Funds |
4,371,171,076.64 |
| Held-for-trading Financial Assets |
2,112,753,516.54 |
| Notes Receivable |
4,613,313.31 |
| Accounts Receivable |
5,147,931,075.79 |
| Advances to Suppliers |
31,251,246.82 |
| Other Receivables |
12,100,079.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,003,642,548.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
100,000,000.00 |
| Other Current Assets |
128,025,273.37 |
| Total Current Assets |
12,919,449,862.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,541,535,618.82 |
| Under-construction Projects |
715,963,034.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
289,504,240.94 |
| R&D expenses |
63,630,342.42 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
130,721,549.56 |
| Deferred Income Tax Assets |
72,814,661.77 |
| Other Non-Current Assets |
671,754,453.87 |
| Sub-Total of Non-Current Assets |
4,334,426,655.70 |
| Total Assets |
17,253,876,518.46 |
| Short-Term Loans |
150,110,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
40,669,758.65 |
| Accounts Payable |
296,073,601.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
162,599,763.26 |
| Taxes Payable |
211,693,083.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,369,285,504.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,887,979.44 |
| Other Current Liabilities |
719,781.04 |
| Sub-Total of Current Liabilities |
3,277,283,030.96 |
| Long-term Loans |
117,887,800.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,363,871.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
198,959,116.33 |
| Total Liabilities |
3,476,242,147.29 |
| Paid-In Capital(Or Share Stock) |
906,070,705.00 |
| Capital Surplus |
3,728,953,879.65 |
| Surplus Reserve |
549,344,838.42 |
| LESS:Treasury Stock |
200,167,849.60 |
| Undistributed Profits |
8,601,973,630.12 |
| Minority Stockholder's Interest |
191,459,167.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,586,175,203.59 |
| Owner's Equity（Stockholder's Equity） |
13,777,634,371.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,253,876,518.46 |
